Global Melanoma Therapeutics Market 2015-2019

黒色腫治療薬の世界市場:皮膚黒色腫(CM)、眼内黒色腫(OM)、粘膜黒色腫(MM)

◆タイトル:Global Melanoma Therapeutics Market 2015-2019
◆商品コード:IRTNTR5573
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年4月1日
◆ページ数:67
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、黒色腫治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、黒色腫治療薬の世界市場規模及び予測、カテゴリー別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Melanoma
According to Melanoma Research Foundation, melanoma is usually, but not always, a cancer of the skin. Melanoma is defined as a cancer that occurs in melanocytes (cells that make the pigment melanin). Chest and back in men and legs in women are the most likely parts to be affected with melanoma. CM, MM, and OM are the three major categories of melanoma. The exact etiology of melanoma is unknown. According to the American Skin Association, the incidence of melanoma is increasing worldwide. The median age of diagnosis is 59 years and the median age of death due to melanoma is 67 years.

TechNavio’s analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.40 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Melanoma Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of melanoma that are available in the market. The market is divided into four segments: CM, OM, MM, and Others.

TechNavio’s report, Global Melanoma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• BMS
• Merck
• Roche

[Other Prominent Vendors]
• AB Science
• Amgen
• Bayer
• Celgene
• Daiichi Sankyo
• Eisai
• Galectin Therapeutics
• GSK
• Novartis
• Pfizer
• Vical
• ZIOPHARM

[Market Driver]
• Increase in Prevalence of Melanoma
• For a full, detailed list, view our report

[Market Challenge]
• Availability of Alternative Treatments
• For a full, detailed list, view our report

[Market Trend]
• Emergence of Combination Therapies
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
3.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Disease Overview
06.1 Understanding the Disease
06.2 Etiology
06.3 Key Statistics
06.4 Stages
06.5 Symptoms
06.6 Checklist of Melanoma

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Melanoma Therapeutics Market in US
07.3.1 Market Size and Forecast
07.4 Melanoma Therapeutics Market in UK
07.4.1 Market Size and Forecast
07.5 Melanoma Therapeutics Market in Japan
07.5.1 Market Size and Forecast
07.6 Five Forces Analysis

08.Melanoma Pipeline Landscape
08.1 Key Emerging Pipeline Molecules

09.Market Segmentation by Category

10.Geographical Segmentation

11.Buying Criteria

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 BMS
18.2.2 Merck
18.2.3 Roche
18.2.4 Others
18.3 Other Prominent Vendors

19.Key Vendor Analysis
19.1 Bristol-Myers Squibb
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Key Product Offerings
19.1.4 Revenue by Geography
19.1.5 Business Strategy
19.1.6 Key Information
19.1.7 SWOT Analysis
19.2 F. Hoffmann-La Roche
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Information
19.2.8 SWOT Analysis
19.3 Merck
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Sales by Geography
19.3.6 Business Strategy
19.3.7 Key Developments
19.3.8 SWOT Analysis

20.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Change of Appearance in Skin Moles: Suspicion of Melanoma
Exhibit 3: New Diagnosed Cases of Melanoma 2012
Exhibit 4: Stages of Melanoma
Exhibit 5: Checklist of Melanoma
Exhibit 6: Snapshot of Global Melanoma Therapeutics Market 2014
Exhibit 7: Global Melanoma Therapeutics Market 2014-2019 (US$ million)
Exhibit 8: Melanoma Therapeutics Market in US 2014-2019 (US$ million)
Exhibit 9: Melanoma Therapeutics Market in UK 2014-2019 (US$ million)
Exhibit 10: Melanoma Therapeutics Market in Japan 2014-2019 (US$ million)
Exhibit 11: Segmentation of Global Melanoma Therapeutics Market by Category
Exhibit 12: Segmentation of Global Melanoma Therapeutics Market by Category
Exhibit 13: Segmentation of Global Melanoma Therapeutics Market by Geography 2014
Exhibit 14: Major Drivers of Global Melanoma Therapeutics Market
Exhibit 15: Major Challenges in Global Melanoma Therapeutics Market
Exhibit 16: Major Trends in Global Melanoma Therapeutics Market
Exhibit 17: BMS: Global Revenue 2009-2012 (US$ million)
Exhibit 18: BMS: Revenue of Yervoy in US 2011-2014 (US$ million)
Exhibit 19: Merck: YoY Revenue 2010-2013 (US$ billion)
Exhibit 20: Roche: Pharmaceutical Sales by Therapeutic Area 2013
Exhibit 21: Segmentation of Global Melanoma Therapeutics Market by Vendor 2014
Exhibit 22: Bristol-Myers Squibb: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 23: Bristol-Myers Squibb: Revenue by Geographical Segmentation 2013
Exhibit 24: Business Segmentation of Roche 2013
Exhibit 25: Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 26: Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 27: Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 28: Merck: Business Segmentation by Revenue 2013
Exhibit 29: Merck: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 30: Merck: Sales by Geography 2013



【掲載企業】

BMS, Merck, Roche, AB Science, Amgen, Bayer, Celgene, Daiichi Sankyo, Eisai, Galectin Therapeutics, GSK, Novartis, Pfizer, Vical, ZIOPHARM

【資料のキーワード】

黒色腫、治療薬、皮膚黒色腫(CM)、眼内黒色腫(OM)、粘膜黒色腫(MM)、皮膚がん、医薬品、パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[黒色腫治療薬の世界市場:皮膚黒色腫(CM)、眼内黒色腫(OM)、粘膜黒色腫(MM)] (Global Melanoma Therapeutics Market 2015-2019 / IRTNTR5573)販売に関する免責事項
[黒色腫治療薬の世界市場:皮膚黒色腫(CM)、眼内黒色腫(OM)、粘膜黒色腫(MM)] (Global Melanoma Therapeutics Market 2015-2019 / IRTNTR5573)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆